Status:
RECRUITING
Mortality and Cardiovascular Diseases in Adult-onset Type 1 Diabetes
Lead Sponsor:
Karolinska Institutet
Conditions:
Type 1 Diabetes
Type 2 Diabetes
Eligibility:
All Genders
18-110 years
Brief Summary
Scarce evidence is available for prognosis in adult-onset type 1 diabetes (T1D). The aim of this study is to investigate the risk of all-cause mortality, cause-specific mortality, and incident CVD in ...
Detailed Description
Introduction Type 1 diabetes (T1D) is traditionally considered as childhood-onset disease while it occurs more often in adults than in children, with a median onset-age of 29 years\[1\]. There is a sc...
Eligibility Criteria
Inclusion
- people with adult-onset (≥18 years) T1D diagnosed in 2001-2020 from the National Diabetes Register
- all T2D cases diagnosed at age ≥18 years in 2001-2020 recorded in the National Diabetes Register
- Everyone with T1D was matched by age, sex, and county to 50 population controls from the Total Population Register.
Exclusion
- To avoid diabetes secondary to pancreatic cancer, we excluded people diagnosed with cancer in the digestive system 1 year prior to diabetes diagnosis and with pancreatic cancer as the underlying cause of death.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
900000 Patients enrolled
Trial Details
Trial ID
NCT06563401
Start Date
January 1 2024
End Date
July 1 2025
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska institute
Stockholm, Sweden, 17177